121 related articles for article (PubMed ID: 36326013)
1. Targeted activation of
Luo N; Zhong W; Li J; Zhai Z; Lu J; Dong R
Nanomedicine (Lond); 2022 Aug; 17(20):1411-1427. PubMed ID: 36326013
[No Abstract] [Full Text] [Related]
2. Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery.
Luo N; Li J; Chen Y; Xu Y; Wei Y; Lu J; Dong R
Drug Deliv; 2021 Dec; 28(1):10-18. PubMed ID: 33336604
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges.
Luo N; Zhong W; Li J; Lu J; Dong R
Mol Biol Rep; 2022 Dec; 49(12):11403-11408. PubMed ID: 35960410
[TBL] [Abstract][Full Text] [Related]
4. Exosome-mediated activation of toll-like receptor 3 in stellate cells stimulates interleukin-17 production by γδ T cells in liver fibrosis.
Seo W; Eun HS; Kim SY; Yi HS; Lee YS; Park SH; Jang MJ; Jo E; Kim SC; Han YM; Park KG; Jeong WI
Hepatology; 2016 Aug; 64(2):616-31. PubMed ID: 27178735
[TBL] [Abstract][Full Text] [Related]
5. FOXA2 alleviates CCl
Wang W; Yao LJ; Shen W; Ding K; Shi PM; Chen F; He J; Ding J; Zhang X; Xie WF
Sci Rep; 2017 Nov; 7(1):15532. PubMed ID: 29138513
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.
Chen L; Yao X; Yao H; Ji Q; Ding G; Liu X
FASEB J; 2020 Apr; 34(4):5178-5192. PubMed ID: 32061112
[TBL] [Abstract][Full Text] [Related]
7. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
[TBL] [Abstract][Full Text] [Related]
8. ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis.
Wu B; Feng J; Guo J; Wang J; Xiu G; Xu J; Ning K; Ling B; Fu Q; Xu J
Stem Cell Res Ther; 2022 Oct; 13(1):494. PubMed ID: 36195966
[TBL] [Abstract][Full Text] [Related]
9. Direct reprogramming of fibroblasts into functional hepatocytes via CRISPRa activation of endogenous Gata4 and Foxa3.
Li J; Li R; Bai X; Zhang W; Nie Y; Hu S
Chin Med J (Engl); 2024 Jun; 137(11):1351-1359. PubMed ID: 38721807
[TBL] [Abstract][Full Text] [Related]
10. Small-Molecule-Mediated Split-Aptamer Assembly for Inducible CRISPR-dCas9 Transcription Activation.
Liu XH; Li BR; Ying ZM; Tang LJ; Wang F; Jiang JH
ACS Chem Biol; 2022 Jul; 17(7):1769-1777. PubMed ID: 35700146
[TBL] [Abstract][Full Text] [Related]
11. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis.
Lou G; Yang Y; Liu F; Ye B; Chen Z; Zheng M; Liu Y
J Cell Mol Med; 2017 Nov; 21(11):2963-2973. PubMed ID: 28544786
[TBL] [Abstract][Full Text] [Related]
12. Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: a role for exosomes in metabolic switch of liver nonparenchymal cells.
Wan L; Xia T; Du Y; Liu J; Xie Y; Zhang Y; Guan F; Wu J; Wang X; Shi C
FASEB J; 2019 Jul; 33(7):8530-8542. PubMed ID: 30970216
[TBL] [Abstract][Full Text] [Related]
13. Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.
Narmada BC; Kang Y; Venkatraman L; Peng Q; Sakban RB; Nugraha B; Jiang X; Bunte RM; So PT; Tucker-Kellogg L; Mao HQ; Yu H
Hum Gene Ther; 2013 May; 24(5):508-19. PubMed ID: 23527815
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis.
Zhao J; Tang N; Wu K; Dai W; Ye C; Shi J; Zhang J; Ning B; Zeng X; Lin Y
PLoS One; 2014; 9(10):e108005. PubMed ID: 25303175
[TBL] [Abstract][Full Text] [Related]
16. Exosome Adherence and Internalization by Hepatic Stellate Cells Triggers Sphingosine 1-Phosphate-dependent Migration.
Wang R; Ding Q; Yaqoob U; de Assuncao TM; Verma VK; Hirsova P; Cao S; Mukhopadhyay D; Huebert RC; Shah VH
J Biol Chem; 2015 Dec; 290(52):30684-96. PubMed ID: 26534962
[TBL] [Abstract][Full Text] [Related]
17. Effects of Exosomes Derived From
Zahmatkesh ME; Jahanbakhsh M; Hoseini N; Shegefti S; Peymani A; Dabin H; Samimi R; Bolori S
Front Cell Infect Microbiol; 2022; 12():857570. PubMed ID: 35832384
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT.
Wu K; Ye C; Lin L; Chu Y; Ji M; Dai W; Zeng X; Lin Y
Clin Sci (Lond); 2016 Aug; 130(16):1469-80. PubMed ID: 27226339
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis.
Gao J; Wei B; de Assuncao TM; Liu Z; Hu X; Ibrahim S; Cooper SA; Cao S; Shah VH; Kostallari E
J Hepatol; 2020 Nov; 73(5):1144-1154. PubMed ID: 32389810
[TBL] [Abstract][Full Text] [Related]
20. The combined induction of liver progenitor cells and the suppression of stellate cells by small molecules reverts chronic hepatic dysfunction.
Huang WJ; Zhou X; Fu GB; Ding M; Wu HP; Zeng M; Zhang HD; Xu LY; Gao Y; Wang HY; Yan HX
Theranostics; 2021; 11(11):5539-5552. PubMed ID: 33859762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
